No Link Found Between Hepatitis C Infection and Extrahepatic Cancers
A study of an Asian population failed to find a link between the virus and malignancies outside of the liver.
Pancreatic Cancer
Lynparza Gains Pancreatic Cancer Indication
The US FDA has approved olaparib for the maintenance treatment of some adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) metastatic pancreatic adenocarcinoma.
Gene Fusions Found in Pancreatic, Biliary IOPNs
Patterns of genetic alterations could guide management.
Risk for Cancer Incidence, Mortality Increased With Psoriasis
Overall cancer mortality and mortality for liver, esophageal, pancreatic cancer up with severe psoriasis.
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
ASTRO Issues Guideline for Radiation Treatment in Pancreatic Cancer
Evidence reviewed for radiation therapy in adjuvant, neoadjuvant, definitive, and palliative settings.
Analysis of Cardiovascular Disease Risks With Different Types of Cancer
Population-based cohort study demonstrated associations between many site-specific cancers and the development of CVDs.
USPSTF Reaffirms Recommends Against Screening for Pancreatic Cancer
Potential benefits of screening do not outweigh potential harms in asymptomatic adults.
Early Closure of Phase 2 Trial on Checkpoint Inhibitors in Metastatic PDAC Due to Missed Efficacy End Point
Pancreatic ductal adenocarcinoma is characterized by a tumor microenvironment that inhibits immune signaling.
Phase 3 Study Evaluating Novel Therapy for Pancreatic Cancer Discontinued
Boston Biomedical has announced that the CanStem111P study investigating napabucasin in patients with metastatic pancreatic cancer will be discontinued due to futility.
- Loading...
Loading...
Next post in Pancreatic Cancer
Loading... 
Loading...